
In a recent study, women who underwent medically-assisted reproduction were more likely to experience negative psychiatric effects because of remaining childless after treatment.

In a recent study, women who underwent medically-assisted reproduction were more likely to experience negative psychiatric effects because of remaining childless after treatment.

Researchers examine disparities in areas lacking medicine and tech.

Becton, Dickinson and Company has announced its BD Vaginal Panel received 510(k) clearance from the FDA.

In a recent study, Black and Hispanic patients were more likely to experience postpartum emergency department care.

Addressing barriers for women doctors could reduce pay gap while expanding the workforce, researchers say.

In a recent study, female offspring of mothers with a positive COVID-19 test during pregnancy were at a decreased risk of developing neurodevelopmental disorders compared to male offspring.

In a recent study, the risk of developing breast cancer was greater in women with current or recent use of progestogen-only contraceptives.

The 2012 Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline was recently reviewed by a panel of clinician experts for use in adults hospitalized with hyperglycemia.

New meta-analysis show patient demographics—as well as their pre-existing comorbidities and COVID-19 vaccination status—may significantly define their risk of long-term conditions.

Study examines effects of law that makes records available to patients.

In a recent study, women with symptomatic uterine fibroids saw reduced symptom burden and improved quality of life after 24 weeks of treatment through relugolix combination therapy.

In a recent study, uterine-sparing techniques led to reduced rates of recurrence and reintervention in patients with adenomyosis.

The patient, referred to as the “New York patient,” was treated with stem cells from cord blood, and has remained HIV-free in her blood since her transplant in 2017.

In a recent review, children with vaccination against human papillomavirus (HPV) initiated at a younger age were more likely to receive their full vaccination series.

Study links visit length to whether doctors make appropriate prescribing decisions.

A recent report from the CDC showed an increase in maternal mortality rates from 2019 and 2020 to 2021.

In a recent review, significant variety and dearth was found in the quality of supportive data which influences recommendations for use of medications in lactating women.

Visby Medical has announced its second generation point of care test for detecting sexually transmitted diseases in women has received 510(k) clearance and a CLIA waiver from the FDA.

In a recent study, active management for early pregnancy loss, also known as miscarriage, was seen less often in emergency departments compared to outpatient clinics.

Despite telehealth’s popularity during the pandemic, many still don’t about it and other home health innovations.

In a recent study, women taking higher cumulative dosages of hormone therapy had a reduced risk of developing lung cancer.

The risk of congenital heart diseases in offspring was increased among mothers with preconception previous hepatitis B virus (HBV) infection.

In a recent study, women who experienced intimate partner violence early in the COVID-19 pandemic reported worse mental health symptoms and modifiable health factors.

Covis, the manufacturer of the controversial preterm birth prevention drug Makena, has announced it will voluntarily withdraw the drug from the market after recommendations from the Center for Drug Evaluation and Research.

NEJM opinion piece highlights how lawmakers are intruding into medicine – with little or no expertise

In ProgenyHealth’s 2023 key trends and insights report, vital areas to observe in pregnancy and childbirth are discussed.


Experts still advocate for breast milk, but pediatricians must be able to offer advice on all options for feeding babies.

POLL: How do you compare with your colleagues in your comfort level for prescribing hormone replacement therapy for symptoms of menopause.

GSK plc has announced positive results for safety and tolerance of dostarlimab (Jemperli; GSK plc) in treating women with endometrial cancer.